
Sign up to save your podcasts
Or


The FDA has approved another immunotherapy to fight a deadly cancer known as multiple myeloma. We meet the first patients to receive this novel therapy and meet the medical team that made it happen.
By The University of Kansas Health System5
1212 ratings
The FDA has approved another immunotherapy to fight a deadly cancer known as multiple myeloma. We meet the first patients to receive this novel therapy and meet the medical team that made it happen.

11 Listeners

0 Listeners

3 Listeners